| Mr Christopher Bocker, OTR/L | |
|
11400 Se 6th St, Ste 105, Bellevue, WA 98004-6419 | |
| (206) 448-1906 | |
| Not Available |
| Full Name | Mr Christopher Bocker |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 31 Years |
| Location | 11400 Se 6th St, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275562449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2066 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Esrc Pllc | 9638254907 | 4 |
News Archive
More than 5 million Americans today are affected by Alzheimer's disease (AD). If nothing is done to stop this upward trajectory, there will be more than 16 million people with AD in the United States and more than 60 million people with AD worldwide by 2050.
Interleukin Genetics, Inc. today announced that it has received commitments from certain institutional investors to purchase approximately $5.3 million of securities in a registered direct offering.
A new report from the American Cancer Society outlines progress made and -more importantly-challenges that remain in fighting childhood cancer. The report estimates the number of new cancer cases and deaths for children and adolescents in the United States, summarizes the most recent and comprehensive data on cancer incidence, mortality, and survival, and outlines what is known and where answers are still needed for childhood cancers.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
› Verified 6 days ago
| Provider Name | Esrc Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1699796755 PECOS PAC ID: 9638254907 Enrollment ID: O20080311000365 |
News Archive
More than 5 million Americans today are affected by Alzheimer's disease (AD). If nothing is done to stop this upward trajectory, there will be more than 16 million people with AD in the United States and more than 60 million people with AD worldwide by 2050.
Interleukin Genetics, Inc. today announced that it has received commitments from certain institutional investors to purchase approximately $5.3 million of securities in a registered direct offering.
A new report from the American Cancer Society outlines progress made and -more importantly-challenges that remain in fighting childhood cancer. The report estimates the number of new cancer cases and deaths for children and adolescents in the United States, summarizes the most recent and comprehensive data on cancer incidence, mortality, and survival, and outlines what is known and where answers are still needed for childhood cancers.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Bocker, OTR/L 11400 Se 6th St, Ste 105, Bellevue, WA 98004-6419 Ph: (206) 448-1906 | Mr Christopher Bocker, OTR/L 11400 Se 6th St, Ste 105, Bellevue, WA 98004-6419 Ph: (206) 448-1906 |
News Archive
More than 5 million Americans today are affected by Alzheimer's disease (AD). If nothing is done to stop this upward trajectory, there will be more than 16 million people with AD in the United States and more than 60 million people with AD worldwide by 2050.
Interleukin Genetics, Inc. today announced that it has received commitments from certain institutional investors to purchase approximately $5.3 million of securities in a registered direct offering.
A new report from the American Cancer Society outlines progress made and -more importantly-challenges that remain in fighting childhood cancer. The report estimates the number of new cancer cases and deaths for children and adolescents in the United States, summarizes the most recent and comprehensive data on cancer incidence, mortality, and survival, and outlines what is known and where answers are still needed for childhood cancers.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
› Verified 6 days ago
Kimberly Lum, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16411 Ne 24th St, Bellevue, WA 98008 Phone: 425-456-5787 | |
Teresa Suhrbier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13010 Ne 20th St Ste 300, Bellevue, WA 98005 Phone: 425-644-6328 | |
Kristin M. Henkes, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Ms. Brooke Eytchison, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2800 Northup Way # 260, Bellevue, WA 98004 Phone: 425-827-5877 | |
Jessica Seminary, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2515 140th Ave Ne Ste E110, Bellevue, WA 98005 Phone: 425-644-4100 | |
Shu-min Lin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 919 109th Ave Ne, Bellevue, WA 98004 Phone: 425-531-7084 | |
Laura Jo Flanigan, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 844-620-1839 |